Five-year incidence, progression, and risk factors for age-related macular degeneration: the age, gene/environment susceptibility study.
about
Role of Nrf2/HO-1 system in development, oxidative stress response and diseases: an evolutionarily conserved mechanismAge-related macular degeneration and mortality in community-dwelling elders: the age, gene/environment susceptibility Reykjavik studyEffect of High-Density Lipoprotein Metabolic Pathway Gene Variations and Risk Factors on Neovascular Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy in China.A Validated Phenotyping Algorithm for Genetic Association Studies in Age-related Macular Degeneration.High-Density Lipoprotein Function in Exudative Age-Related Macular DegenerationIncidence and Growth of Geographic Atrophy during 5 Years of Comparison of Age-Related Macular Degeneration Treatments Trials.Incidence of Age-Related Macular Degeneration in a Multi-Ethnic United States Population: The Multi-Ethnic Study of Atherosclerosis.The Association between the Lipids Levels in Blood and Risk of Age-Related Macular Degeneration.The evidence informing the surgeon's selection of intraocular lens on the basis of light transmittance properties.Lipids, oxidized lipids, oxidation-specific epitopes, and Age-related Macular Degeneration.[Epidemiology of age-related macular degeneration].Effects of white light-emitting diode (LED) exposure on retinal pigment epithelium in vivo.Review of the association between retinal microvascular characteristics and eye disease.HDL-cholesterol levels and risk of age-related macular degeneration: a multiethnic genetic study using Mendelian randomization.Extended Intravitreal Rabbit Eye Residence of Nanoparticles Conjugated With Cationic Arginine Peptides for Intraocular Drug Delivery: In Vivo Imaging
P2860
Q26751266-7A02CA0C-F4A0-40BB-B663-B47DB4C503B5Q28386582-F99D3F94-DA3C-4A6D-9D4E-78B7A7CED6F7Q35857083-5F457FCE-6562-4317-932C-FFCA3CA7FB20Q35932943-B9EDF461-C1C7-4C99-BB16-E2AD4CFB9171Q36015473-A0B0A24A-39E6-4C01-9786-5E88BBCB9872Q36247080-93D68790-6D6E-4CBF-AE4F-B74731E1E35CQ36927671-122523E4-8EB1-4252-B048-4945F5430F1AQ37374027-498AE9AB-77F9-46AB-9F19-BB1DF9CCA975Q37639903-55D34AF8-7AB3-4946-9884-9F1685DE740BQ38915148-F32DE969-126D-4F3F-A0A7-D28182F0C01FQ40615188-53B23272-F8E2-4440-A444-DE7A0BCA0C62Q42511711-41694C42-3531-4BB1-9A90-6B4695B62A2FQ48200470-2EDDAFEC-2FF8-4151-99C9-C6A1F25D443EQ50100117-AF8D45F1-CE41-4638-AC0F-CBB6272B9BF6Q58806008-48644941-3F51-42E0-8AD4-A95E7D1826F6
P2860
Five-year incidence, progression, and risk factors for age-related macular degeneration: the age, gene/environment susceptibility study.
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Five-year incidence, progressi ...... ironment susceptibility study.
@ast
Five-year incidence, progressi ...... ironment susceptibility study.
@en
Five-year incidence, progressi ...... ironment susceptibility study.
@nl
type
label
Five-year incidence, progressi ...... ironment susceptibility study.
@ast
Five-year incidence, progressi ...... ironment susceptibility study.
@en
Five-year incidence, progressi ...... ironment susceptibility study.
@nl
prefLabel
Five-year incidence, progressi ...... ironment susceptibility study.
@ast
Five-year incidence, progressi ...... ironment susceptibility study.
@en
Five-year incidence, progressi ...... ironment susceptibility study.
@nl
P2093
P2860
P50
P1433
P1476
Five-year incidence, progressi ...... ironment susceptibility study.
@en
P2093
Diana E Fisher
Fridbert Jonasson
Ronald Klein
Sigurdur Sigurdsson
P2860
P304
P356
10.1016/J.OPHTHA.2014.03.013
P577
2014-04-24T00:00:00Z